EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut microbiota as a key regulator in endometriosis: mechanisms, therapeutic opportunities, and future perspectives

Xiaojun Liu, Minghui Fan, Yang Wang, Dongyun He, Li Liu

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2025.1730739 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Xiaojun Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Endometriosis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometriosis (EMs), a common and frequently occurring gynecological disease, is a major cause of chronic pelvic pain and infertility in women. Its pathogenesis remains unclear to date, and it is characterized by high invasiveness and recurrence tendency. Although the specific pathogenesis of EMs has not been clarified, existing studies have confirmed that gut microbiota dysbiosis plays an important role in its pathogenic process. Studies suggest that gut microbiota may affect the occurrence and progression of EMs through immunoinflammatory pathways and metabolic pathways (such as enhanced estrogen metabolism and abnormal lipid metabolism). Meanwhile, approaches including dietary intervention, supplementation of probiotics or prebiotics, and microbiota transplantation can help prevent and alleviate EMs symptoms, providing potential therapeutic methods. This article will review the research progress on the correlation between gut microbiota dysbiosis and EMs, with the aim of offering more references for the diagnosis and treatment of EMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisGastrointestinal MicrobiomeHumansFemaleProbioticsDysbiosisPrebioticsEstrogensAnimals

Stichwörter der Autor:innen

endometriosisestrogen metabolismgut microbiotainflammationprobiotics

Substanzen

PrebioticsEstrogens

Autor:innen und Institutionen

  • Reproductive Medicine Center, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
  • Department of Dermatology, Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China.

Zitieren

APA

Liu, X., Fan, M., Wang, Y., He, D., & Liu, L. (2026). Gut microbiota as a key regulator in endometriosis: mechanisms, therapeutic opportunities, and future perspectives. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1730739

Vancouver

Liu X, Fan M, Wang Y, He D, Liu L. Gut microbiota as a key regulator in endometriosis: mechanisms, therapeutic opportunities, and future perspectives. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2025.1730739

BibTeX
@article{Liu2026,
  author = {Liu, Xiaojun and Fan, Minghui and Wang, Yang and He, Dongyun and Liu, Li},
  title = {Gut microbiota as a key regulator in endometriosis: mechanisms, therapeutic opportunities, and future perspectives},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2025.1730739}
}
Kostenlos starten →